Dopamine Receptor D3 Induces Transient, mTORC1-Dependent Autophagy That Becomes Persistent, AMPK-Mediated, and Neuroprotective in Experimental Models of Huntington’s Disease
Cells · 2025
DOI: 10.3390/cells14090652 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Diego Luis-Ravelo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biomedical Technologies, University of La Laguna, 38200 Tenerife, Spain. Hauptthemen laut MEDLINE: Huntington Disease, Autophagy, Mechanistic Target of Rapamycin Complex 1, Receptors, Dopamine D3. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovación y Universidades, Spanish Ministry of Science, Innovation and Universities, Spanish Ministry of Economy and Competitiveness.
Abstract (Originalsprache)
Huntington disease’s (HD) is a neurodegenerative disorder caused by the expansion of a polyglutamine region (PolyQ) within the huntingtin protein (HTT). Mutated huntingtin (mHTT) is cytotoxic, particularly for striatal medium spiny neurons (MSNs), whose degeneration is the hallmark of HD. Autophagy inducers currently available promote the clearance of toxic proteins. However, due to their low selectivity and the possibility that prolonged autophagy hampers essential processes in unaffected cells, researchers have questioned their benefits in neurodegenerative diseases. Since MSNs express dopamine receptors D2 (DRD2) and D3 (DRD3) and DRD2/DRD3 agonists may activate autophagy, here, we explored how healthy and mHTT-challenged cells respond to prolonged DRD2/DRD3 agonist treatment. Autophagy activation and its effects on mHTT/polyQ clearance were studied in R6/1 mice (a genetic model of HD), their wild-type littermates, and DRD2- and DRD3-HEK cells expressing a pathogenic (Q74) and a non-pathogenic (Q23) polyQ fragment of mHTT treated with the DRD2/DRD3 agonist pramipexole. Two forms of DRD3-mediated autophagy were found: a transient mTORC1-dependent in WT mice and Q23-DRD3-HEK cells and a persistent AMPK-ULK1-activated in R6/1 mice and Q74-DRD3-HEK cells. This also promoted a robust clearance of soluble mHTT/polyQ and neuroprotection in striatal neurons and DRD3-HEK cells. The findings indicate that DRD3-induced autophagy may be a safe, disease-modifying intervention in HD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biomedical Technologies, University of La Laguna, 38200 Tenerife, Spain.
- Department of Basic Medical Sciences, Faculty of Medicine, University of La Laguna, 38200 Tenerife, Spain.
- Department of Medical and Translational Biology, Umeå University, 901 87 Umeå, Sweden.
ORCID-Profile: Felipe Fumagallo-Reading, Alejandro Febles-Casquero, Jonathan Lopez-Fernandez, Daniel J Marcellino, Tomas Gonzalez-Hernandez
Förderung
- Ministerio de Ciencia, Innovación y Universidades
- Spanish Ministry of Science, Innovation and Universities
- Spanish Ministry of Economy and Competitiveness
Zitieren
APA
Luis-Ravelo, D., Fumagallo-Reading, F., Febles-Casquero, A., Lopez-Fernandez, J., Marcellino, D. J., & Gonzalez-Hernandez, T. (2025). Dopamine Receptor D3 Induces Transient, mTORC1-Dependent Autophagy That Becomes Persistent, AMPK-Mediated, and Neuroprotective in Experimental Models of Huntington’s Disease. Cells. https://doi.org/10.3390/cells14090652
Vancouver
Luis-Ravelo D, Fumagallo-Reading F, Febles-Casquero A, Lopez-Fernandez J, Marcellino DJ, Gonzalez-Hernandez T. Dopamine Receptor D3 Induces Transient, mTORC1-Dependent Autophagy That Becomes Persistent, AMPK-Mediated, and Neuroprotective in Experimental Models of Huntington’s Disease. Cells. 2025. doi:10.3390/cells14090652
BibTeX
@article{LuisRavelo2025,
author = {Luis-Ravelo, Diego and Fumagallo-Reading, Felipe and Febles-Casquero, Alejandro and Lopez-Fernandez, Jonathan and Marcellino, Daniel J and Gonzalez-Hernandez, Tomas},
title = {Dopamine Receptor D3 Induces Transient, mTORC1-Dependent Autophagy That Becomes Persistent, AMPK-Mediated, and Neuroprotective in Experimental Models of Huntington’s Disease},
journal = {Cells},
year = {2025},
doi = {10.3390/cells14090652}
}
EUVIMED